[Use of antiretroviral drugs in HIV infected children in a tropical area: a real benefit].
Timité-Konan
A M
AM
Fassinou
P
P
Adonis-Koffy
L
L
N'dja
B B
BB
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology; D000293:Adolescent; D000480:Alkynes; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D015897:Comorbidity; D007560:Cote d'Ivoire / Q000453:epidemiology; D003521:Cyclopropanes; D003906:Developing Countries; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008297:Male; D044342:Malnutrition / Q000453:epidemiology; D019888:Nelfinavir / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D017320:HIV Protease Inhibitors; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D019888:Nelfinavir; C098320:efavirenz
Les antirétroviraux chez l'enfant VIH positif en milieu tropical: un bénéfice certain.